Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT05688202
Eligibility Criteria:
Inclusion Criteria:
* Patients with post-acne atrophic scars on both facial sides visiting HCMC Hospital of Venereology and Dermatology in the conducting period;
* Agreement to give written informed consent and authorization for release of personal health data.
Exclusion Criteria:
* Patients in pregnancy or lactation
* Patients who use oral isotretinoin within the preceding six months or topical retinoids (tretinoin, retinol, tazoretin, tazarotene) within the preceding two weeks
* Patients with active moderate-severe acne vulgaris
* Patients with a history of keloid/hypertrophic scar formation
* Patients undergone cosmetic procedure (filler injections, botulinum toxin A, ablative/non-ablative laser resurfacing procedures, chemical reconstruction of skin scars, collagen induction therapy using a microneedle therapy system at the treatment site within the preceding six months
* Patients undergoing immunosuppressive therapy
* Patients currently using anticoagulative or antiplatelet medications
* Patients with active infections at the treatment sites; (i) patients with systemic diseases (heart failure, diabetes,…)
* Patients with active Herpes simplex infections at the treatment sites.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05688202
Study Brief:
Protocol Section:
NCT05688202